UNIQURE NV's ticker is QURE and the CUSIP is N90064101. A total of 133 filers reported holding UNIQURE NV in Q1 2019. The put-call ratio across all filers is 0.11 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $1,162,000 | -6.7% | 34,500 | 0.0% | 0.01% | -14.3% |
| Q4 2020 | $1,246,000 | -2.0% | 34,500 | 0.0% | 0.01% | -22.2% |
| Q3 2020 | $1,271,000 | -18.3% | 34,500 | 0.0% | 0.02% | -18.2% |
| Q2 2020 | $1,555,000 | +4.0% | 34,500 | +9.5% | 0.02% | -24.1% |
| Q1 2020 | $1,495,000 | -27.8% | 31,500 | +9.0% | 0.03% | -12.1% |
| Q4 2019 | $2,071,000 | +70.3% | 28,900 | -6.5% | 0.03% | +43.5% |
| Q3 2019 | $1,216,000 | -43.6% | 30,900 | +12.0% | 0.02% | -37.8% |
| Q2 2019 | $2,157,000 | -5.6% | 27,600 | -27.9% | 0.04% | -70.6% |
| Q1 2019 | $2,285,000 | +693.4% | 38,300 | +283.0% | 0.13% | +563.2% |
| Q4 2018 | $288,000 | -60.2% | 10,000 | -49.7% | 0.02% | -58.7% |
| Q3 2018 | $724,000 | -5.2% | 19,900 | -1.5% | 0.05% | -29.2% |
| Q2 2018 | $764,000 | – | 20,200 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 155,500 | $11,803,000 | 2.66% |
| Aquilo Capital Management, LLC | 901,490 | $16,290,000 | 2.39% |
| Nantahala Capital Management | 2,811,459 | $50,803,000 | 2.25% |
| Privium Fund Management B.V. | 493,229 | $8,913,000 | 1.97% |
| 683 Capital Management, LLC | 1,355,000 | $24,485,000 | 1.31% |
| Henry James International Management Inc. | 125,622 | $2,270,000 | 0.90% |
| Integral Health Asset Management, LLC | 170,000 | $3,072,000 | 0.80% |
| Nantahala Capital Management | 890,000 | $16,082,000 | 0.71% |
| Sonic Fund II, L.P. | 50,000 | $904,000 | 0.51% |
| Voss Capital, LLC | 70,000 | $1,265,000 | 0.40% |